[CAS NO. 3102-57-6]  C2 Ceramide

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [3102-57-6]

Distributor
Catalog
AS939441
Brand
Arctom Scientific
CAS
3102-57-6

DESCRIPTION [3102-57-6]

Overview

MDLMFCD07374281
Molecular Weight341.53
Molecular FormulaC20H39NO3
SMILESO[C@H](/C=C/CCCCCCCCCCCCC)[C@H](CO)NC(C)=O

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE


Summary

C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP) . C2 Ceramide induces cells differentiation, autophagy and apoptosis , inhibits mitochondrial respiratory chain complex III . C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss [1] [2] [3] [4] [5] .


IC50 & Target

Protein phosphatase 1 [2]
PP2A [4]
Ceramide-activated protein phosphatase (CAPP) [4]
Apoptosis [1]
Mitochondrial respiratory chain complex III [1]


In Vitro

C2 Ceramide (5 nM-200 µM; 24 hours; primary mouse osteoblasts) treatment (≤500 nM) promots osteoblast viability, whilst concentrations ≥2 µM significantly reduces osteoblast viability in a dose- and time-dependent manner [1] .
C2 Ceramide increases cytoplasmic histone-associated DNA fragments by 5.7- and 11.2-fold at 50 µM and 100 µM C2 Ceramide concentrations respectively in osteoblasts. At these higher concentrations, C2 Ceramide is a potent inducer of apoptosis in osteoblasts [1] .
C2 Ceramide up-regulates mRNA expression of angiogenic genes in human dental pulp cells (HDPCs) and increases the migration and capillary tube formation of endothelial cells, whereas PP1 small interfering RNA shows opposite effects. Human dental pulp cells (HDPCs) increases levels of bone morphogenetic protein 2, phosphorylation of Smad 1/5/8, and mRNA expression of runt-related transcription factor 2 and osterix [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: Primary mouse osteoblasts
Concentration: 5 nM-200 µM
Incubation Time: 24 hours
Result: Murine osteoblasts demonstrated a dose-dependent increase in their survival rate when exposed to low concentrations of 5-500 n M. Increasing concentrations of 20-200µM caused a dose-dependent decrease in mitochondrial succinate dehydrogenase activity and osteoblast survival.

In Vivo

The PP1 activator C2 Ceramide increases alkaline phosphatase activity, mineralizes nodule formation, and mRNA expression of dentin matrix protein 1 and dentin sialophosphoprotein. In contrast, knockdown by PP1 small interfering RNA inhibits odontoblastic differentiation [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

-20°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 20 mg/mL ( 58.56 mM ; Need ultrasonic and warming)

Ethanol : 17 mg/mL ( 49.78 mM ; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.9280 mL 14.6400 mL 29.2800 mL
5 mM 0.5856 mL 2.9280 mL 5.8560 mL
10 mM 0.2928 mL 1.4640 mL 2.9280 mL
* Please refer to the solubility information to select the appropriate solvent.


Synonyms

Acetamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
Acetamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (E)-D-erythro-
Acetamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-
Acetamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-
N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]acetamide
N-Acetyl-C18-sphingosine
D-erythro-1,3-Dihydroxy-2-acetamido-trans-4-octadecene
N-Acetylsphingosine
D-erythro-C2-Ceramide
C2-Ceramide
D-erythro-N-Acetylsphingosine
N-Acetyl-D-erythro-sphingosine
N-Acetyl-D-sphingosine
Ceramide 2